BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mealey KL. Therapeutic implications of the MDR-1 gene. J Vet Pharmacol Ther. 2004;27:257-264. [PMID: 15500562 DOI: 10.1111/j.1365-2885.2004.00607.x] [Cited by in Crossref: 118] [Cited by in F6Publishing: 126] [Article Influence: 6.9] [Reference Citation Analysis]
Number Citing Articles
1 Mealey KL, Owens JG, Freeman E. Canine and feline P‐glycoprotein deficiency: What we know and where we need to go. Vet Pharm & Therapeutics 2022. [DOI: 10.1111/jvp.13102] [Reference Citation Analysis]
2 Beckers E, Casselman I, Soudant E, Daminet S, Paepe D, Peelman L, Broeckx BJG. The prevalence of the ABCB1-1Δ variant in a clinical veterinary setting: The risk of not genotyping. PLoS ONE 2022;17:e0273706. [DOI: 10.1371/journal.pone.0273706] [Reference Citation Analysis]
3 Choudhary S, Abongwa M, Kashyap SS, Verma S, Mair GR, Kulke D, Martin RJ, Robertson AP. Nodulisporic acid produces direct activation and positive allosteric modulation of AVR-14B, a glutamate-gated chloride channel from adult Brugia malayi. Proc Natl Acad Sci U S A 2022;119:e2111932119. [PMID: 35969762 DOI: 10.1073/pnas.2111932119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Clark TP. The history and pharmacology of buprenorphine: New advances in cats. Vet Pharm & Therapeutics 2022;45. [DOI: 10.1111/jvp.13073] [Reference Citation Analysis]
5 Sophocleous RA, Ooi L, Sluyter R. The P2X4 Receptor: Cellular and Molecular Characteristics of a Promising Neuroinflammatory Target. Int J Mol Sci 2022;23:5739. [PMID: 35628550 DOI: 10.3390/ijms23105739] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Garcia ÍR, de Oliveira Garcia FA, Pereira PS, Coutinho HDM, Siyadatpanah A, Norouzi R, Wilairatana P, de Lourdes Pereira M, Nissapatorn V, Tintino SR, Rodrigues FFG. Microbial resistance: The role of efflux pump superfamilies and their respective substrates. Life Sci 2022;:120391. [PMID: 35149116 DOI: 10.1016/j.lfs.2022.120391] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Jimenez TP. Genetic Disease. Canine and Feline Anesthesia and Co‐Existing Disease 2022. [DOI: 10.1002/9781119604075.ch11] [Reference Citation Analysis]
8 Pietra M, Galiazzo G, Bresciani F, Morini M, Licarini S, Turba ME, Amaducci G, Bettini G, Fracassi F, Ostanello F. Evaluation of Prognostic Factors, including Duodenal P-Glycoprotein Expression, in Canine Chronic Enteropathy. Animals (Basel) 2021;11:2315. [PMID: 34438774 DOI: 10.3390/ani11082315] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Singh L, Singh K. Ivermectin: A Promising Therapeutic for Fighting Malaria. Current Status and Perspective. J Med Chem 2021;64:9711-31. [PMID: 34242031 DOI: 10.1021/acs.jmedchem.1c00498] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Wilson NE, Reaves BJ, Wolstenholme AJ. Lack of detectable short-term effects of a single dose of ivermectin on the human immune system. Parasit Vectors 2021;14:304. [PMID: 34090504 DOI: 10.1186/s13071-021-04810-6] [Reference Citation Analysis]
11 Guillen A, Smallwood K, Killick DR. Molecular pathology in the cancer clinic - where are we now and where are we headed? J Small Anim Pract 2021;62:507-20. [PMID: 33974272 DOI: 10.1111/jsap.13330] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Lynn RC, Duquette RA. Antiparasitic drugs. Georgis' Parasitology for Veterinarians 2021. [DOI: 10.1016/b978-0-323-54396-5.00015-5] [Reference Citation Analysis]
13 Rosa B. Equine Drug Transporters: A Mini-Review and Veterinary Perspective. Pharmaceutics 2020;12:E1064. [PMID: 33171593 DOI: 10.3390/pharmaceutics12111064] [Reference Citation Analysis]
14 Ferreira da Cruz FS, Natalini CC, Pellin de Molnar BF, Beatriz da Silva Serpa P, Tisotti T, Midon M, Desessards de La Côrte F. Tramadol Effects on Lameness Score After Inhibition of P-GP by Ivermectin Administration in Horses: Preliminary Results. J Equine Vet Sci 2020;92:103163. [PMID: 32797786 DOI: 10.1016/j.jevs.2020.103163] [Reference Citation Analysis]
15 Ferreira J. Preanaesthetic screening in dogs and cats. In pract 2020;42:197-207. [DOI: 10.1136/inp.m1448] [Reference Citation Analysis]
16 Okazaki F, Tsuji Y, Seto Y, Ogami C, Yamamoto Y, To H. Effects of a rifampicin pre-treatment on linezolid pharmacokinetics. PLoS One 2019;14:e0214037. [PMID: 31518346 DOI: 10.1371/journal.pone.0214037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
17 Thamm DH, Gustafson DL. Drug dose and drug choice: Optimizing medical therapy for veterinary cancer. Vet Comp Oncol 2020;18:143-51. [PMID: 31487110 DOI: 10.1111/vco.12537] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Valencia Ayala E, Marcos Carbajal P, Coelho EB, Sandoval JS, Salazar Granara A. Geographic distribution of the 3435C>T polymorphism of the MDR1 gene in Peruvian populations. Drug Metab Pers Ther 2019;34. [PMID: 31323002 DOI: 10.1515/dmpt-2018-0041] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
19 Virkel G, Ballent M, Lanusse C, Lifschitz A. Role of ABC Transporters in Veterinary Medicine: Pharmaco- Toxicological Implications. CMC 2019;26:1251-69. [DOI: 10.2174/0929867325666180201094730] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
20 Mealey KL, Martinez SE, Villarino NF, Court MH. Personalized medicine: going to the dogs? Hum Genet 2019;138:467-81. [PMID: 31032534 DOI: 10.1007/s00439-019-02020-w] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
21 Maués T, El-Jaick KB, Costa FB, Freitas PVS, Moreira AS, Castro L, Ferreira MLG, Ferreira AMR. Could polymorphisms in ABCB1 gene represent a genetic risk factor for the development of mammary tumors in dogs? Vet J 2019;248:58-63. [PMID: 31113564 DOI: 10.1016/j.tvjl.2019.04.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Lahmers SM. Cardiovascular Pharmacotherapeutics. Pharmacotherapeutics for Veterinary Dispensing 2019. [DOI: 10.1002/9781119404576.ch10] [Reference Citation Analysis]
23 Okazaki F, Tsuji Y, Seto Y, Ogami C, Yamamoto Y, To H. Effects of a rifampicin pre-treatment on linezolid pharmacokinetics.. [DOI: 10.1101/572610] [Reference Citation Analysis]
24 Gustafson DL, Bailey DB. Cancer Chemotherapy. Withrow and MacEwen's Small Animal Clinical Oncology 2019. [DOI: 10.1016/b978-0-323-59496-7.00012-8] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
25 Slensky K, Clifford CA. Sick Oncology Patients in the Emergency Room. Textbook of Small Animal Emergency Medicine 2018. [DOI: 10.1002/9781119028994.ch72] [Reference Citation Analysis]
26 Krohn M, Wanek T, Menet MC, Noack A, Declèves X, Langer O, Löscher W, Pahnke J. Humanization of the Blood-Brain Barrier Transporter ABCB1 in Mice Disrupts Genomic Locus - Lessons from Three Unsuccessful Approaches. Eur J Microbiol Immunol (Bp) 2018;8:78-86. [PMID: 30345087 DOI: 10.1556/1886.2018.00008] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 de Castro Rodrigues D, Buzullini C, Pereira TA, Curz BC, Gomes LVC, Soares VE, Bastos TSA, Couto LFM, Lopes WDZ, de Oliveira GP, Costa AJD. Avermectin toxicity in bovines less than thirty days old. Research in Veterinary Science 2018;118:403-12. [DOI: 10.1016/j.rvsc.2018.04.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
28 Gwaltney-brant SM, Declementi C, Gupta RC. Macrocyclic Lactone Endectocides. Veterinary Toxicology 2018. [DOI: 10.1016/b978-0-12-811410-0.00043-x] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
29 Whitehouse-Tedd KM, Smith L, Budd JA, Lloyd CG. Suspected adverse reactions to oral administration of a praziquantel-pyrantel combination in captive cheetahs (Acinonyx jubatus). J Am Vet Med Assoc 2017;251:1188-95. [PMID: 29099259 DOI: 10.2460/javma.251.10.1188] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Levick B, Laudisoit A, Tepage F, Ensoy-Musoro C, Mandro M, Bonareri Osoro C, Suykerbuyk P, Kashama JM, Komba M, Tagoto A, Falay D, Begon M, Colebunders R. High prevalence of epilepsy in onchocerciasis endemic regions in the Democratic Republic of the Congo. PLoS Negl Trop Dis 2017;11:e0005732. [PMID: 28708828 DOI: 10.1371/journal.pntd.0005732] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 8.8] [Reference Citation Analysis]
31 Wang J, Wang Y, Pan Y, Chen D, Liu Z, Feng L, Peng D, Yuan Z. Preparation of a generic monoclonal antibody and development of a highly sensitive indirect competitive ELISA for the detection of phenothiazines in animal feed. Food Chemistry 2017;221:1004-13. [DOI: 10.1016/j.foodchem.2016.11.062] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
32 Ito D, Childress M, Mason N, Winter A, O’brien T, Henson M, Borgatti A, Lewellen M, Krick E, Stewart J, Lahrman S, Rajwa B, Scott MC, Seelig D, Koopmeiners J, Ruetz S, Modiano J. A double blinded, placebo-controlled pilot study to examine reduction of CD34+/CD117+/CD133+ lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000Res 2017;4:42. [DOI: 10.12688/f1000research.6055.2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
33 Hu Y, Zhang M, Lu B, Dai J. Helicobacter pylori and Antibiotic Resistance, A Continuing and Intractable Problem. Helicobacter. 2016;21:349-363. [PMID: 26822340 DOI: 10.1111/hel.12299] [Cited by in Crossref: 68] [Cited by in F6Publishing: 72] [Article Influence: 11.3] [Reference Citation Analysis]
34 Mealey KL, Fidel J. P-glycoprotein mediated drug interactions in animals and humans with cancer. J Vet Intern Med 2015;29:1-6. [PMID: 25619511 DOI: 10.1111/jvim.12525] [Cited by in Crossref: 46] [Cited by in F6Publishing: 47] [Article Influence: 6.6] [Reference Citation Analysis]
35 Bates N. Effects of exposure to human medicines in cats and dogs. The Veterinary Nurse 2015;6:482-487. [DOI: 10.12968/vetn.2015.6.8.482] [Reference Citation Analysis]
36 van Beusekom CD, Lange R, Schrickx JA. A functional model for feline P-glycoprotein. J vet Pharmacol Therap 2016;39:95-7. [DOI: 10.1111/jvp.12248] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
37 Monobe MM, Junior JPA, Lunsford KV, Silva RC, Bulla C. Frequency of the MDR1 mutant allele associated with multidrug sensitivity in dogs from Brazil. Vet Med (Auckl) 2015;6:111-7. [PMID: 30101099 DOI: 10.2147/VMRR.S72373] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
38 Ito D, Childress M, Mason N, Winter A, O'Brien T, Henson M, Borgatti A, Lewellen M, Krick E, Stewart J, Lahrman S, Rajwa B, Scott MC, Seelig D, Koopmeiners J, Ruetz S, Modiano J. A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000Res 2015;4:42. [PMID: 28357033 DOI: 10.12688/f1000research.6055.3] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
39 Ito D, Childress M, Mason N, Winter A, O'Brien T, Henson M, Borgatti A, Lewellen M, Krick E, Stewart J, Lahrman S, Rajwa B, Scott MC, Seelig D, Koopmeiners J, Ruetz S, Modiano J. A double blinded, placebo-controlled pilot study to examine reduction of CD34 +/CD117 +/CD133 + lymphoma progenitor cells and duration of remission induced by neoadjuvant valspodar in dogs with large B-cell lymphoma. F1000Res 2015;4:42. [PMID: 28357033 DOI: 10.12688/f1000research.6055.3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
40 Larson VS, Madden V. Complications of Chemotherapy Agents. Small Animal Critical Care Medicine 2015. [DOI: 10.1016/b978-1-4557-0306-7.00173-2] [Reference Citation Analysis]
41 Muir WW. Factors Influencing Analgesic Drug Selection, Dose, and Routes of Drug Administration. Handbook of Veterinary Pain Management 2015. [DOI: 10.1016/b978-0-323-08935-7.00015-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
42 Silva R, Vilas-Boas V, Carmo H, Dinis-Oliveira RJ, Carvalho F, de Lourdes Bastos M, Remião F. Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy. Pharmacol Ther 2015;149:1-123. [PMID: 25435018 DOI: 10.1016/j.pharmthera.2014.11.013] [Cited by in Crossref: 211] [Cited by in F6Publishing: 226] [Article Influence: 26.4] [Reference Citation Analysis]
43 Heckler R, Almeida G, Santos L, Borges D, Neves J, Onizuka M, Borges F. P-gp modulating drugs greatly potentiate the in vitro effect of ivermectin against resistant larvae of Haemonchus placei. Veterinary Parasitology 2014;205:638-45. [DOI: 10.1016/j.vetpar.2014.08.002] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
44 Barnard RA, Wittenburg LA, Amaravadi RK, Gustafson DL, Thorburn A, Thamm DH. Phase I clinical trial and pharmacodynamic evaluation of combination hydroxychloroquine and doxorubicin treatment in pet dogs treated for spontaneously occurring lymphoma. Autophagy 2014;10:1415-25. [PMID: 24991836 DOI: 10.4161/auto.29165] [Cited by in Crossref: 122] [Cited by in F6Publishing: 128] [Article Influence: 15.3] [Reference Citation Analysis]
45 Griffin CE. Diagnosis of Canine Atopic Dermatitis. Veterinary Allergy 2013. [DOI: 10.1002/9781118738818.ch10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
46 Mealey KL. Adverse Drug Reactions in Veterinary Patients Associated with Drug Transporters. Veterinary Clinics of North America: Small Animal Practice 2013;43:1067-78. [DOI: 10.1016/j.cvsm.2013.04.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
47 Yang T, Xu F, Xu J, Fang D, Yu Y, Chen Y. Comparison of liquid chromatography-tandem mass spectrometry-based targeted proteomics and conventional analytical methods for the determination of P-glycoprotein in human breast cancer cells. J Chromatogr B Analyt Technol Biomed Life Sci 2013;936:18-24. [PMID: 23968647 DOI: 10.1016/j.jchromb.2013.07.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
48 Molento M, Veríssimo C, Amarante A, van Wyk J, Chagas A, Araújo JD, Borges F. Alternativas para o controle de nematoides gastrintestinais de pequenos ruminantes. Arq Inst Biol 2013;80:253-63. [DOI: 10.1590/s1808-16572013000200018] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
49 Spencer PS, Vandemaele K, Richer M, Palmer VS, Chungong S, Anker M, Ayana Y, Opoka ML, Klaucke BN, Quarello A, Tumwine JK. Nodding syndrome in Mundri county, South Sudan: environmental, nutritional and infectious factors. Afr Health Sci 2013;13:183-204. [PMID: 24235915 DOI: 10.4314/ahs.v13i2.2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 32] [Article Influence: 0.4] [Reference Citation Analysis]
50 Gray LL, Hillier A, Cole LK, Rajala-schultz PJ. The Effect of Ketoconazole on Whole Blood and Skin Ciclosporin Concentrations in Dogs. Advances in Veterinary Dermatology 2013. [DOI: 10.1002/9781118644317.ch16] [Reference Citation Analysis]
51 Retournard M, Cadiergues M. Utilisation de la ciclosporine en dermatologie féline : données actuelles. Pratique Médicale et Chirurgicale de l'Animal de Compagnie 2013;48:33-40. [DOI: 10.1016/j.anicom.2013.01.002] [Reference Citation Analysis]
52 Gray LL, Hillier A, Cole LK, Rajala-schultz PJ. The effect of ketoconazole on whole blood and skin ciclosporin concentrations in dogs: Blood and skin ciclosporin concentrations. Veterinary Dermatology 2013;24:118-e28. [DOI: 10.1111/j.1365-3164.2012.01064.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
53 Epstein SE, Hollingsworth SR. Ivermectin-induced blindness treated with intravenous lipid therapy in a dog: Ivermectin-induced blindness treated with intralipid therapy. Journal of Veterinary Emergency and Critical Care 2013;23:58-62. [DOI: 10.1111/vec.12016] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 2.9] [Reference Citation Analysis]
54 Osselaere A, Li SJ, De Bock L, Devreese M, Goossens J, Vandenbroucke V, Van Bocxlaer J, Boussery K, Pasmans F, Martel A, De Backer P, Croubels S. Toxic effects of dietary exposure to T-2 toxin on intestinal and hepatic biotransformation enzymes and drug transporter systems in broiler chickens. Food Chem Toxicol 2013;55:150-5. [PMID: 23313610 DOI: 10.1016/j.fct.2012.12.055] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
55 Gustafson DL, Page RL. Cancer Chemotherapy. Withrow and MacEwen's Small Animal Clinical Oncology. Elsevier; 2013. pp. 157-79. [DOI: 10.1016/b978-1-4377-2362-5.00011-6] [Cited by in Crossref: 21] [Article Influence: 2.3] [Reference Citation Analysis]
56 Lai Y. P-glycoprotein (P-gp/MDR1)/ABCB1. Transporters in Drug Discovery and Development 2013. [DOI: 10.1533/9781908818287.147] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
57 Muñana K, Nettifee-osborne J, Bergman R, Mealey K. Association between ABCB1 Genotype and Seizure Outcome in Collies with Epilepsy. J Vet Intern Med 2012;26:1358-64. [DOI: 10.1111/j.1939-1676.2012.01006.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
58 Geyer J, Janko C. Treatment of MDR1 mutant dogs with macrocyclic lactones. Curr Pharm Biotechnol 2012;13:969-86. [PMID: 22039792 DOI: 10.2174/138920112800399301] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 3.8] [Reference Citation Analysis]
59 Parton K, Wiffen E, Haglund N, Cave N. Macrocyclic lactone toxicity due to abamectin in farm dogs without the ABCB1 gene mutation. New Zealand Veterinary Journal 2012;60:194-7. [DOI: 10.1080/00480169.2011.642770] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
60 Linardi RL, Stokes AM, Andrews FM. The effect of P-Glycoprotein on methadone hydrochloride flux in equine intestinal mucosa: Effects of P-gp on methadone intestinal flux. Journal of Veterinary Pharmacology and Therapeutics 2013;36:43-50. [DOI: 10.1111/j.1365-2885.2012.01390.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
61 Gwaltney-brant SM, Declementi C, Gupta RC. Macrocyclic lactone endectocides. Veterinary Toxicology. Elsevier; 2012. pp. 609-19. [DOI: 10.1016/b978-0-12-385926-6.00051-x] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
62 Wright HM, Chen AV, Talcott PA, Poppenga RH, Mealey KL. Intravenous fat emulsion as treatment for ivermectin toxicosis in three dogs homozygous for the ABCB1-1Δ gene mutation: Intravenous fat emulsion for ivermectin toxicosis. Journal of Veterinary Emergency and Critical Care 2011;21:666-72. [DOI: 10.1111/j.1476-4431.2011.00687.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
63 Krugman L, Bryan JN, Mealey KL, Chen A. Vincristine-induced central neurotoxicity in a collie homozygous for the ABCB1Δ mutation. J Small Anim Pract 2012;53:185-7. [PMID: 22122243 DOI: 10.1111/j.1748-5827.2011.01155.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
64 Huang B, Zhao L, Sun J, Zhang J, Zhang Y, Zhang K, Jin J, Xie M. Establishment and Validation of a Time-Resolved Fluoroimmunoassay for Chlorpromazine. Food Anal Methods 2012;5:625-30. [DOI: 10.1007/s12161-011-9286-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
65 Borges FA, Rossini JB, Velludo PP, Buzzulini C, Costa GH, Molento MB, Costa AJ. Weak phenotypic reversion of ivermectin resistance in a field resistant isolate of Haemonchus contortus by verapamil. Pesq Vet Bras 2011;31:731-6. [DOI: 10.1590/s0100-736x2011000900002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
66 Gramer I, Leidolf R, Döring B, Klintzsch S, Krämer E, Yalcin E, Petzinger E, Geyer J. Breed distribution of the nt230(del4) MDR1 mutation in dogs. The Veterinary Journal 2011;189:67-71. [DOI: 10.1016/j.tvjl.2010.06.012] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.5] [Reference Citation Analysis]
67 Mealey KL. ABCG2 transporter: therapeutic and physiologic implications in veterinary species: ABCG2 transporter. Journal of Veterinary Pharmacology and Therapeutics 2012;35:105-12. [DOI: 10.1111/j.1365-2885.2011.01313.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
68 Peigñan L, Garrido W, Segura R, Melo R, Rojas D, Cárcamo JG, San Martín R, Quezada C. Combined use of anticancer drugs and an inhibitor of multiple drug resistance-associated protein-1 increases sensitivity and decreases survival of glioblastoma multiforme cells in vitro. Neurochem Res 2011;36:1397-406. [PMID: 21544552 DOI: 10.1007/s11064-011-0464-8] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
69 Buur J. Distribution. Comparative Pharmacokinetics 2011. [DOI: 10.1002/9780470959916.ch5] [Reference Citation Analysis]
70 Iragüen D, Urcelay S, San Martín B. Pharmacovigilance in veterinary medicine in Chile: a pilot study. J Vet Pharmacol Ther 2011;34:108-15. [PMID: 21395600 DOI: 10.1111/j.1365-2885.2010.01201.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
71 Dunn ST, Hedges L, Sampson KE, Lai Y, Mahabir S, Balogh L, Locuson CW. Pharmacokinetic Interaction of the Antiparasitic Agents Ivermectin and Spinosad in Dogs. Drug Metab Dispos 2011;39:789-95. [DOI: 10.1124/dmd.110.034827] [Cited by in Crossref: 35] [Cited by in F6Publishing: 38] [Article Influence: 3.2] [Reference Citation Analysis]
72 Gadeyne C, Van der Heyden S, Gasthuys F, Croubels S, Schauvliege S, Polis I. The influence of modulation of P-glycoprotein and /or Cytochrome P450 3A on the pharmacokinetics and pharmacodynamics of orally administered morphine in dogs: Modulating oral morphine absorption in dogs. Journal of Veterinary Pharmacology and Therapeutics 2011;34:417-23. [DOI: 10.1111/j.1365-2885.2010.01264.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
73 Kukanich B. Clinical interpretation of pharmacokinetic and pharmacodynamic data in zoologic companion animal species. Vet Clin North Am Exot Anim Pract 2011;14:1-20. [PMID: 21074699 DOI: 10.1016/j.cvex.2010.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
74 Al-Bataineh MM, van der Merwe D, Schultz BD, Gehring R. Tumor necrosis factor alpha increases P-glycoprotein expression in a BME-UV in vitro model of mammary epithelial cells. Biopharm Drug Dispos 2010;31:506-15. [PMID: 21104926 DOI: 10.1002/bdd.731] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
75 Camenzind R, Chip S, Gutmann H, Kapfhammer J, Nitsch C, Bendfeldt K. Preservation of transendothelial glucose transporter 1 and P-glycoprotein transporters in a cortical slice culture model of the blood–brain barrier. Neuroscience 2010;170:361-71. [DOI: 10.1016/j.neuroscience.2010.06.073] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
76 Bourguinat C, Kamgno J, Boussinesq M, Mackenzie CD, Prichard RK, Geary TG. Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event. Am J Trop Med Hyg 2010;83:28-32. [PMID: 20595473 DOI: 10.4269/ajtmh.2010.09-0734] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
77 Skottheim IB, Jakobsen GS, Stormark K, Christensen H, Hjelmesæth J, Jenssen T, Åsberg A, Sandbu R. Significant Increase in Systemic Exposure of Atorvastatin After Biliopancreatic Diversion With Duodenal Switch. Clin Pharmacol Ther 2010;87:699-705. [DOI: 10.1038/clpt.2010.32] [Cited by in Crossref: 33] [Cited by in F6Publishing: 36] [Article Influence: 2.8] [Reference Citation Analysis]
78 Martinez M, Modric S. Patient variation in veterinary medicine: part I. Influence of altered physiological states: Variability in drug response. Journal of Veterinary Pharmacology and Therapeutics 2010;33:213-26. [DOI: 10.1111/j.1365-2885.2009.01139.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.1] [Reference Citation Analysis]
79 Gustafson DL, Thamm DH. Pharmacokinetic modeling of doxorubicin pharmacokinetics in dogs deficient in ABCB1 drug transporters. J Vet Intern Med 2010;24:579-86. [PMID: 20337920 DOI: 10.1111/j.1939-1676.2010.0496.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
80 Brayden DJ, Oudot EJM, Baird AW. Drug Delivery Systems in Domestic Animal Species. In: Cunningham F, Elliott J, Lees P, editors. Comparative and Veterinary Pharmacology. Berlin: Springer Berlin Heidelberg; 2010. pp. 79-112. [DOI: 10.1007/978-3-642-10324-7_4] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
81 Riviere JE. New Technologies for Application to Veterinary Therapeutics. In: Cunningham F, Elliott J, Lees P, editors. Comparative and Veterinary Pharmacology. Berlin: Springer Berlin Heidelberg; 2010. pp. 191-210. [DOI: 10.1007/978-3-642-10324-7_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
82 Spencer ES, Minch J, Lahmers KK, Haldorson GJ, Mealey KL. Canine ABCB4: Tissue expression and cDNA structure. Res Vet Sci 2010;89:65-71. [PMID: 20153493 DOI: 10.1016/j.rvsc.2010.01.012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
83 Kukanich B, Hubin M. The pharmacokinetics of ketoconazole and its effects on the pharmacokinetics of midazolam and fentanyl in dogs. Journal of Veterinary Pharmacology and Therapeutics 2010;33:42-9. [DOI: 10.1111/j.1365-2885.2009.01105.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
84 Turkanovic J, Ngo SNT, Milne RW. Effect of St John's wort on the disposition of fexofenadine in the isolated perfused rat liver. Journal of Pharmacy and Pharmacology 2010;61:1037-1042. [DOI: 10.1211/jpp.61.08.0007] [Reference Citation Analysis]
85 Van Der Heyden S, Chiers K, Ducatelle R. Tissue Distribution of P-Glycoprotein in Cats. Anatomia, Histologia, Embryologia 2009;38:455-60. [DOI: 10.1111/j.1439-0264.2009.00972.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
86 Vail DM. Supporting the veterinary cancer patient on chemotherapy: neutropenia and gastrointestinal toxicity. Top Companion Anim Med 2009;24:122-9. [PMID: 19732730 DOI: 10.1053/j.tcam.2009.02.004] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
87 Dorababu M, Nishimura A, Prabha T, Naruhashi K, Sugioka N, Takada K, Shibata N. Effect of cyclosporine on drug transport and pharmacokinetics of nifedipine. Biomed Pharmacother. 2009;63:697-702. [PMID: 19819100 DOI: 10.1016/j.biopha.2009.04.031] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.5] [Reference Citation Analysis]
88 Cobb R, Boeckh A. Moxidectin: a review of chemistry, pharmacokinetics and use in horses. Parasit Vectors 2009;2 Suppl 2:S5. [PMID: 19778466 DOI: 10.1186/1756-3305-2-S2-S5] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.6] [Reference Citation Analysis]
89 Tydén E, Tallkvist J, Tjälve H, Larsson P. P-glycoprotein in intestines, liver, kidney and lymphocytes in horse. J Vet Pharmacol Ther 2009;32:167-76. [PMID: 19290947 DOI: 10.1111/j.1365-2885.2008.01017.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
90 Skottheim IB, Stormark K, Christensen H, Jakobsen GS, Hjelmesaeth J, Jenssen T, Reubsaet JL, Sandbu R, Asberg A. Significantly altered systemic exposure to atorvastatin acid following gastric bypass surgery in morbidly obese patients. Clin Pharmacol Ther 2009;86:311-8. [PMID: 19494810 DOI: 10.1038/clpt.2009.82] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 4.6] [Reference Citation Analysis]
91 Rodrigues AC, Hirata MH, Hirata RDC. Impact of cholesterol on ABC and SLC transporters expression and function and its role in disposition variability to lipid-lowering drugs. Pharmacogenomics 2009;10:1007-16. [DOI: 10.2217/pgs.09.18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
92 Grabowski T, Jaroszewski JJ. Bioavailability of veterinary drugs in vivo and in silico. Journal of Veterinary Pharmacology and Therapeutics 2009;32:249-57. [DOI: 10.1111/j.1365-2885.2008.01034.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
93 Li YH, Wang YH, Li Y, Yang L. MDR1 gene polymorphisms and clinical relevance. Yi Chuan Xue Bao 2006;33:93-104. [PMID: 16529292 DOI: 10.1016/S0379-4172(06)60027-9] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
94 Bissonnette S, Paradis M, Daneau I, Silversides DW. The ABCB1-1Δ mutation is not responsible for subchronic neurotoxicity seen in dogs of non-collie breeds following macrocyclic lactone treatment for generalized demodicosis. Veterinary Dermatology 2009;20:60-6. [DOI: 10.1111/j.1365-3164.2008.00731.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
95 Barbet JL, Snook T, Gay JM, Mealey KL. ABCB1-1 Delta (MDR1-1 Delta) genotype is associated with adverse reactions in dogs treated with milbemycin oxime for generalized demodicosis. Vet Dermatol 2009;20:111-4. [PMID: 19171022 DOI: 10.1111/j.1365-3164.2008.00725.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
96 Yu C, Argyropoulos G, Zhang Y, Kastin AJ, Hsuchou H, Pan W. Neuroinflammation activates Mdr1b efflux transport through NFkappaB: promoter analysis in BBB endothelia. Cell Physiol Biochem 2008;22:745-56. [PMID: 19088456 DOI: 10.1159/000185558] [Cited by in Crossref: 35] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
97 Zhou SF. Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition. Xenobiotica. 2008;38:802-832. [PMID: 18668431 DOI: 10.1080/00498250701867889] [Cited by in Crossref: 387] [Cited by in F6Publishing: 333] [Article Influence: 27.6] [Reference Citation Analysis]
98 Zalloum HM, Taha MO. Development of predictive in silico model for cyclosporine- and aureobasidin-based P-glycoprotein inhibitors employing receptor surface analysis. J Mol Graph Model 2008;27:439-51. [PMID: 18789739 DOI: 10.1016/j.jmgm.2008.07.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
99 Haritova AM, Schrickx J, Lashev LD, Fink-gremmels J. Expression of MDR1, MRP2 and BCRP mRNA in tissues of turkeys. Journal of Veterinary Pharmacology and Therapeutics 2008;31:378-85. [DOI: 10.1111/j.1365-2885.2008.00968.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
100 Martinez M, Modric S, Sharkey M, Troutman L, Walker L, Mealey K. The pharmacogenomics of P-glycoprotein and its role in veterinary medicine. Journal of Veterinary Pharmacology and Therapeutics 2008;31:285-300. [DOI: 10.1111/j.1365-2885.2008.00964.x] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 3.3] [Reference Citation Analysis]
101 Lespine A, Alvinerie M, Vercruysse J, Prichard RK, Geldhof P. ABC transporter modulation: a strategy to enhance the activity of macrocyclic lactone anthelmintics. Trends Parasitol 2008;24:293-8. [PMID: 18514030 DOI: 10.1016/j.pt.2008.03.011] [Cited by in Crossref: 77] [Cited by in F6Publishing: 77] [Article Influence: 5.5] [Reference Citation Analysis]
102 Han QL, Zhang LF, Zhang XD, Jin XW, Yang L, Wang X, Ding J. Role of Ss-A/Ro ribonucleoprotein 60 ku subunit variant 1 in multi-drug resistance of gastric cancer. Shijie Huaren Xiaohua Zazhi 2008; 16(8): 814-818 [DOI: 10.11569/wcjd.v16.i8.814] [Reference Citation Analysis]
103 Fleischer S, Sharkey M, Mealey K, Ostrander EA, Martinez M. Pharmacogenetic and metabolic differences between dog breeds: their impact on canine medicine and the use of the dog as a preclinical animal model. AAPS J 2008;10:110-9. [PMID: 18446511 DOI: 10.1208/s12248-008-9011-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 68] [Article Influence: 4.6] [Reference Citation Analysis]
104 Riviere JE. The future of veterinary therapeutics: A glimpse towards 2030. The Veterinary Journal 2007;174:462-71. [DOI: 10.1016/j.tvjl.2007.06.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
105 Brayden DJ, Griffin J. Avermectin transepithelial transport in MDR1- and MRP-transfected canine kidney monolayers. Vet Res Commun 2008;32:93-106. [DOI: 10.1007/s11259-007-9007-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
106 Schrickx J, Fink-Gremmels J. P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model. J Vet Pharmacol Ther 2007;30:25-31. [PMID: 17217397 DOI: 10.1111/j.1365-2885.2007.00808.x] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
107 Schrickx JA, Fink-gremmels J. D08 Ex vivo P-glycoprotein inhibition in porcine lymphocytes. J Vet Pharmacol Ther 2006;29:120-120. [DOI: 10.1111/j.1365-2885.2006.00762_10.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
108 Han QL, Zhang XD, Ding J, Jin XW, Yang L, Wang X, Zhang XY, Fan DM. Reversal of multidrug resistance in gastric cancer cell line by Ss-A/Ro ribonucleoprotein 60-ku subunit antisense nucleic acid. Shijie Huaren Xiaohua Zazhi 2006; 14(27): 2668-2672 [DOI: 10.11569/wcjd.v14.i27.2668] [Reference Citation Analysis]
109 Trepanier LA. Cytochrome P450 and Its Role in Veterinary Drug Interactions. Veterinary Clinics of North America: Small Animal Practice 2006;36:975-85. [DOI: 10.1016/j.cvsm.2006.05.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
110 Henik RA, Kellum HB, Bentjen SA, Mealey KL. Digoxin and Mexiletine Sensitivity in a Collie with the MDR1 Mutation. Journal of Veterinary Internal Medicine 2006;20:415-7. [DOI: 10.1111/j.1939-1676.2006.tb02878.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
111 Linardi RL, Natalini CC. Multi-drug resistance (MDR1) gene and P-glycoprotein influence on pharmacokinetic and pharmacodymanic of therapeutic drugs. Cienc Rural 2006;36:336-41. [DOI: 10.1590/s0103-84782006000100056] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
112 Natalini CC, Cunha AFD, Linardi RL. Multi-drug resistance gene (MDR1) and opioid analgesia in horses. Cienc Rural 2006;36:330-5. [DOI: 10.1590/s0103-84782006000100055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
113 Raub TJ. P-Glycoprotein Recognition of Substrates and Circumvention through Rational Drug Design. Mol Pharmaceutics 2006;3:3-25. [DOI: 10.1021/mp0500871] [Cited by in Crossref: 175] [Cited by in F6Publishing: 176] [Article Influence: 10.3] [Reference Citation Analysis]
114 Katragadda S, Budda B, Anand BS, Mitra AK. Role of efflux pumps and metabolising enzymes in drug delivery. Expert Opin Drug Deliv 2005;2:683-705. [PMID: 16296794 DOI: 10.1517/17425247.2.4.683] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
115 Kukanich B, Lascelles BDX, Aman AM, Mealey KL, Papich MG. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs. J Vet Pharmacol Ther 2005;28:461-6. [DOI: 10.1111/j.1365-2885.2005.00681.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 3.4] [Reference Citation Analysis]